| Position | Action |
|---|---|
| Price above $115-118 (any strength) | Trim 30-40% of SPCX exposure |
| Prior sizing too conservative (50-70% trim) | Surrenders meaningful convexity—bear thesis is dominant but not certain |
SPCX is a hyper-growth industrial at an investment-phase trough with 34% revenue CAGR, $1.05B Q1 2026 OCF growing +44% YoY, $23.7B liquidity, dominant positioning in launch/LEO/AI infrastructure/defense, and asymmetric Q2 earnings setup favoring bulls over the bear's HOLD.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | 116.62 | bearish |
| 50 SMA | 144.53 | bearish |
| 200 SMA | 144.53 | — |
| MACD | -9.80 | bearish |
| MACD Signal | -9.56 | bearish |
| MACD Histogram | -0.24 | bearish |
| RSI | 35.50 | neutral |
| Bollinger Middle | 126.52 | — |
| ATR | 9.42 | — |
| VWMA | 118.91 | bearish |
Support: 104.83 · 97.9 | Resistance: 116.62 · 118.91 · 126.52 · 144.53 · 155.14
SPCX trades at 114.53, up from 108.37 but remains below all major trend averages. MACD is negative at -9.80 with signal line at -9.56 and histogram at -0.24, confirming bearish momentum. RSI has recovered to 35.50 from deeply oversold levels (28.22-29.22 on multiple July dates) but remains below neutral 50. ATR of 9.42 indicates high volatility. The 200 SMA value of 144.53 is unreliable as it exactly matches the 50 SMA due to limited data history (35 records from 2026-06-12). Bollinger bands span from 97.90 (lower) to 155.14 (upper) with middle at 126.52. Trading posture is HOLD for existing positions; new longs should wait for price to reclaim 116.62 and 118.91 with improving momentum confirmation.
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Trim SPCX 30-40% into strength with $100 put spreads; express bear thesis via measured sizing and convex hedges, not spot-Underweight
The bear case dominates on every quantifiable axis: impossible forward EPS math (requires +$21B swing from -$9.36B TTM net income to ~61% net margins vs -41.6% operating margins within 126.8x forward P/E), 30-100x supply-demand mismatch on $100-104B lockup supply vs $1-3B committed buying interest, decisively bearish technicals (price below 10 EMA $116.62, 50 SMA $144.53, VWAP $118.91, Bollinger $126.52; MACD -9.80, RSI 35.50), OCF of $1.05B covering only 10.4% of $10.1B quarterly capex, and gross margin compression to 49.1%. However, the prior SPCX Underweight call (2026-07-31) returned +5.7% with +4.3% alpha precisely because the reflexive-bounce risk was ignored (RSI 28 + elevated ATR + binary catalyst within 1-2 weeks). Today's setup is materially similar. Lesson explicitly states to express via smaller sizing, options, or post-catalyst entry rather than spot-Underweight into the event. Underweight with measured execution honors this lesson while preserving the asymmetric downside protection the fundamentals justify.
When: Q2 print with clean margin disclosure
Then: Reassess thesis with updated fundamentals
Operating cash flow growth of +44% YoY to $1.05B in Q1 2026 demonstrates the core business engine, while $10.1B capex is growth-funding investment, not operational distress.
↩ rebuts: “Bear framing of -$9.1B quarterly FCF as value destruction”
· concedes: 270 bps gross margin compression to 49.1%; R&D more than doubled to $8.6B in FY2025 and +126% YoY in Q1 2026; Down 44% in 7 weeks from post-IPO momentum peak; $100-104B insider lockup unlock creates float expansion; Forward P/E of 126.8x is elevated for current period; TM revenue multiple of ~82x is rich by conventional standards; Net debt of $14.4B is a concern for some analysts; Bear's HOLD is defensible on near-term volatility basis even if long-term thesis is sound
The "asymmetric setup" is actually asymmetric to the downside: the stock requires 6-7 variable coincidences to hit the bull's $145-160 target, while the bear case requires only 3 confirmations (technical repair, clean Q2 print, lockup absorption) to validate $85-95 range—a 25-35% drawdown from current levels.
· concedes: Starlink is the scale leader in LEO broadband (conceded from bull's thesis); Launch services is dominant in commercial (conceded from bull's thesis); The June peak at $170-225 was speculative post-IPO premium pricing (conceded); The stock is down 36% from 52-week highs (conceded); RSI of 35.50 indicates recovering from oversold (conceded)
→ vs conservative: The HOLD position's 'wait for confirmation' approach is functionally identical to staying long through binary event risk with asymmetric downside, sailing through a known supply tsunami with positions intact
→ vs conservative: Citing 34% revenue CAGR, 44% OCF growth to $1.05B, and $23.7B liquidity as bridge to required 61% net margins from negative 41.6% operating margins is insufficient; these structural strengths cannot bridge a gap requiring complete transformation of cost structure
→ vs conservative: Stop at 104.83 is correctly calibrated to technical invalidation level, not too tight; ATR of 9.42 being elevated is exactly why full size should not be held through binary event
→ vs neutral: The 'wait for confirmation' crowd requires five sequential confirmations (116.62, 118.91, 126.52, RSI crossing 50, MACD crossing signal) while the unlock event occurs Thursday, meaning all confirmations would arrive too late
→ vs neutral: Describing $100-104B unlock as 'sustained supply pressure' is diplomatic understatement; it's a supply avalanche that no oversold RSI bounce at 35.50 can absorb
→ vs neutral: Musk's $115 'insane opportunity' tweet reflects structural conflict of interest as largest insider benefiting if retail holds bid before lockup
→ vs neutral: Ark buying below IPO is a sentiment tell, not fundamental tell, operating on different AUM and time horizon scales than tactical trader needs this week
→ vs neutral: 'Defer to post-earnings analysis' is functionally identical to staying long through binary event risk with asymmetric downside
Market Cap
$1,508,839,653,376
Forward P/E
126.83x
Price to Book
19.23x
EPS TTM
-$0.67
Forward EPS
$0.903
52-Week High
$225.64
52-Week Low
$104.83
50-Day MA
$145.41
200-Day MA
$145.41
Revenue TTM
$19.30B
Gross Profit TTM
$9.42B
EBITDA TTM
$3.95B
Net Income TTM
-$9.36B
Profit Margin TTM
-45.0%
Operating Margin TTM
-41.6%
Debt/Equity
73.6x
Current Ratio
1.22
Book Value/Share
$5.96
FY2023 Revenue
$10,387M
FY2024 Revenue
$14,015M
FY2025 Revenue
$18,674M
FY2023 Net Income
-$4,628M
FY2024 Net Income
$791M
FY2025 Net Income
-$4,937M
FY2023 EBITDA
-$663M
FY2024 EBITDA
$5,646M
FY2025 EBITDA
$4,427M
FY2023 R&D
$2,105M
FY2024 R&D
$3,464M
FY2025 R&D
$8,643M
FY2023 Gross Margin
41.2%
FY2024 Gross Margin
42.9%
FY2025 Gross Margin
49.4%
FY2025 Operating Income
-$2,064M
Q1 2026 Revenue
$4,694M
Q1 2026 Revenue YoY
+15.4%
Q1 2026 Gross Margin
49.1%
Q1 2026 R&D YoY
+125.7%
Q1 2026 Operating Income
-$1,954M
Q1 2026 Net Income
-$4,276M
Q1 2026 EBITDA
-$1,164M
Q1 2026 OCF
$1,047M
Q1 2026 OCF YoY
+44%
Q1 2026 CapEx
$10,114M
Q1 2026 CapEx YoY
+144%
Q1 2026 FCF
-$9,067M
Q1 2026 FCF YoY
+166% worse
FY2023 FCF
$105M
FY2024 FCF
-$5,387M
FY2025 FCF
-$14,121M
FY2024 CapEx
$11,163M
FY2025 CapEx
$20,906M
Q1 2026 Cash
$15,852M
Q1 2026 Short-Term Investments
$7,823M
Q1 2026 Total Liquid Assets
$23,675M
Q1 2026 Total Debt
$30,600M
Q1 2026 Net Debt
$14,410M
Q1 2026 Total Assets
$102,094M
Q1 2026 Total Equity
$41,582M
Q1 2026 Common Equity
$34,533M
Q1 2026 Preferred Equity
$7,049M
Q1 2026 Retained Earnings
-$41,311M
Q1 2026 Net PPE
$55,061M
Q1 2026 Construction in Progress
$14,045M
Q1 2026 Long-Term Debt
$28,727M
FY2025 Net Debt Issuance
$8,902M
FY2025 Net Equity Issuance
$17,682M
Q1 2026 Net Debt Issuance
$4,317M
Q1 2026 Net Equity Issuance
$3,973M
FY2025 Stock-Based Compensation
$1,950M
Q1 2026 Stock-Based Compensation
$639M
FY2025 Interest Expense
$1,945M
Q1 2026 Interest Expense
$664M
Revenue CAGR FY2023-FY2025
~34%
Q1 2026 Diluted Shares
10.6B
FY2025 Diluted Shares
9.65B
Strengths
Concerns
SPCX is executing an aggressive multi-year capital expansion program into Starship, Starlink, and defense infrastructure, burning -$9.07B in FCF in Q1 2026 alone as capex reached $10.11B (annualized ~$40B). While revenue grew 15% YoY to $4.69B with operating cash flow improving 44%, the company posted a -$4.28B net loss as R&D doubled YoY to $3.51B. The capital structure underwent significant transformation with $31.7B in preferred stock converting to common equity while total debt rose 31% to $30.6B. With $23.7B in liquidity against ~$40B annualized capex, the company requires continued capital market access and a successful margin inflection — the forward EPS consensus of $0.90 implies profitability turning positive within the forecast horizon.